Monday, Oct 19, 2026
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"granules-india-limited"
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults
Latest News
Fresh NOTAM: Pakistan extends airspace ban on Indian aircraft until November 24
2 minutes ago
Opinion: Singareni at a crossroads—beneath the coal, a crisis of accountability
9 minutes ago
Reliance Retail faces FDA crackdown again; action also on Blinkit-linked facility
17 minutes ago
Editorial: Stampede deaths—a familiar saga of apathy
30 minutes ago
Lawrence Bishnoi gang claims responsibility for attack on Tiger Shroff
32 minutes ago
US-designated terrorist Muhammad Sarwar dies in Lahore
47 minutes ago
Over 2,000 arrested as violent protests sweep France
1 hour ago
Soham wins gold at CISCE National Taekwondo Championship 2026
1 hour ago